Oral OncologyBioinformaticsPeer-reviewed journal article
Tumor Subtype Classification Tool for HPV-associated Head and Neck Cancers
Shiting LiiD, Bailey Fabiny GarbiD, Tingting QiniD, Sarah SoppeiD, Elizabeth F. LopeziD, Snehal B. PatiliD, Nisha J. D’SilvaiD, Laura S. RozekiD, Maureen A. SartoriD
Abstract
ImportanceMolecular subtypes of HPV-associated Head and Neck Squamous Cell Carcinoma (HNSCC), named IMU (immune strong) and KRT (highly keratinized), are well-recognized and have been shown to have distinct mechanisms of carcinogenesis, clinical outcomes, and potentially differing optimal treatment strategies. Currently, no standardized method exists to subtype a new HPV+ HNSCC tumor. Our paper introduces a machine learning-based classifier and webtool to reliably subtype HPV+ HNSCC tumors using the IMU/KRT paradigm and highlights the importance of subtype in HPV+ HNSCC. ObjectiveTo develop a robust, accurate machine learning-based classification tool that standardizes the process of subtyping HPV+ HNSCC, and to investigate the clinical, demographic, and molecular features associated with subtype in a meta-analysis of four patient cohorts. Data SourcesWe conducted RNA-seq on 67 HNSCC FFPE blocks from University of Michigan hospital. Combining this with three publicly available datasets, we utilized a total of 229 HPV+ HNSCC RNA-seq samples. All participants were HPV+ according to RNA expression. An ensemble machine learning approach with five algorithms and three different input training gene sets were developed, with final subtype determined by majority vote. Several additional steps were taken to ensure rigor and reproducibility throughout. Study SelectionThe classifier was trained and tested using 84 subtype-labeled HPV+ RNA-seq samples from two cohorts: University of Michigan (UM; n=18) and TCGA-HNC (n=66). The classifier robustness was validated with two independent cohorts: 83 samples from the HPV Virome Consortium and 62 additional samples from UM. We revealed 24 of 39 tested clinicodemographic and molecular variables significantly associated with subtype. ResultsThe classifier achieved 100% accuracy in the test set. Validation on two additional cohorts demonstrated successful separation by known features of the subtypes. Investigating the relationship between subtype and 39 molecular and clinicodemographic variables revealed IMU is associated with epithelial-mesenchymal transition (p=2.25x10-04), various immune cell types, and lower radiation resistance (p=0.0050), while KRT is more highly keratinized (p=2.53x10-08), and more likely female than IMU (p=0.0082). Conclusions and RelevanceThis study provides a reliable classifier for subtyping HPV+ HNSCC tumors as either IMU or KRT based on bulk RNA-seq data, and additionally, improves our understanding of the HPV+ HNSCC subtypes.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- approach: machine learning (classical)
- Citations
- 3
- FWCI
- 2.34
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.
A. Chakravarthy, I. Reddin, … T. R. Fenton·bioRxiv·Apr 2, 2020
- A Deep Learning Framework for Predicting Prognostically Relevant Consensus Molecular Subtypes in HPV-Positive Cervical Squamous Cell Carcinoma from Routine Histology Images
Ruoyu Wang, Gozde N. Gunesli, … Nasir Rajpoot·npj Precision OncologyPeer-reviewed·Jan 11, 2025
- Analysis of Divergent Gene Expression between HPV+ and HPV- Head and Neck Squamous Cell Carcinoma Patients
Kasturika Shankar, Sarah E. Walker·Infectious Agents and CancerPeer-reviewed·May 21, 2025
- Integrative immune subtyping of HNSCC reveals clinically relevant phenotypes and treatment-associated transitions
Indu Khatri, Terezinha Maria de Souza, … Iris C. R. M. Kolder·npj Precision OncologyPeer-reviewed·Apr 23, 2026
- Subtype-Specific Dependencies and Drug Vulnerabilities Enable Precision Therapeutics in Head and Neck Cancer
Joel Markus Vaz, Songli Zhu, … Taranjit S. Gujral·bioRxiv·Dec 9, 2025
- Integrative Spatial Analysis of H&E and IHC Images Identifies Prognostic Immune Subtypes Correlated with Progression-Free Survival in HPV-Related Oropharyngeal Squamous Cell Carcinoma
S. R. Nakkireddy, I. Jang, … T. H. Hwang·bioRxiv·Sep 13, 2023